News | Wearables | November 09, 2018

Cardiac Insight Partners With VivoSense for Cardiovascular Research

Partnership will integrate Cardiac Insight’s Cardea Solo ECG wearable biosensor with VivoSense data platform to provide advanced insights into performance of new medicines and therapies

Cardiac Insight Partners With VivoSense for Cardiovascular Research

November 9, 2018 — Wearable cardiac biosensor developer Cardiac Insight Inc. has partnered with VivoSense, specializing in integration and specialized analysis of wearable sensor data for research and clinical trials. Together, both companies will deliver enhanced research analytics to help VivoSense expand the use of wearable biosensors for pharmaceutical clinical trials and other healthcare applications.

Sophisticated new analytics are the key to making sense of the complex data sets generated by human study participants in response to new drug candidates and genetics-driven population health research, according to Dudley Tabakin, CEO and co-founder of VivoSense. The collaboration between the two companies will use the Cardiac Insight Cardea Solo electrocardiogram (ECG) sensor data with VivoSense software, data cleaning, robust analytics and regulatory-compliant biomarkers.

VivoSense ingests data from many different wearable sensors, from high-resolution cardiorespiratory and other cardiac sensors like Cardea Solo to wrist-worn activity trackers. This data from on-body sensors is integrated, cleaned and synchronously analyzed with robust algorithms and scientific oversight from the VivoSense platform.

Comfortable and unobtrusive wearable cardiorespiratory sensors are finding ubiquitous use in sports and fitness research, longitudinal healthcare monitoring and in regulated clinical trials. The very large physiological data sets generated by these sensors are the key to monitoring health and providing a greater understanding of the effects of new medicines and therapies, according to the companies.

For more information: www.cardiacinsightinc.com, www.vivosense.com

Related Content

News | Cardiac Diagnostics

October 4, 2021 – Nanowear, a hospital-at-home and remote diagnostic platform that used proprietary wearable cloth ...

Home October 04, 2021
Home
News | Cardiac Diagnostics

September 28, 2021 — Biotricity Inc., a medical diagnostic and consumer healthcare technology company, has developed a ...

Home September 28, 2021
Home
News | Cardiac Diagnostics

July 29, 2021 — A recent clinical study from Overlake Medical Center utilizing the Bardy Diagnostics Carnation ...

Home July 29, 2021
Home
News | Cardiac Diagnostics

July 1, 2021 — The U.S. Food and Drug Administration (FDA) has cleared the Angel Medical Systems Inc. second-generation ...

Home July 01, 2021
Home
News | Cardiac Diagnostics

March 8, 2021 — In a new study from Shiley Eye Institute at UC San Diego Health, researchers have identified a potential ...

Home March 08, 2021
Home
News | Cardiac Diagnostics

March 3, 2021 — AliveCor recently announced a new collaboration with AstraZeneca to research new disease management ...

Home March 03, 2021
Home
News | Cardiac Diagnostics

February 2, 2021 — A new study has found in the U.S. shows higher economic prosperity was associated with a small ...

Home February 02, 2021
Home
News | Cardiac Diagnostics

January 6, 2021 — Smoking traditional cigarettes in addition to using e-cigarettes results in harmful health effects ...

Home January 06, 2021
Home
News | Cardiac Diagnostics

October 6, 2020 — A new technology being developed by U.S.-based Mesuron Inc. using a superconducting quantum ...

Home October 06, 2020
Home
News | Cardiac Diagnostics

May 11, 2020 — The American Society for Preventive Cardiology (ASPC) is collaborating with Intervent International to ...

Home May 11, 2020
Home
Subscribe Now